CORT
CORT
NASDAQ · Pharmaceuticals

Corcept Therapeutics Inc

$108.35
-2.34 (-2.11%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target -5.6% upside
Low Target $62.31
Average Target $102.33
High Target $121.34
Current Price $108.35
Current
$108.35
Target
$102.33
$62.31 $102.33 avg $121.34
Scenario Analysis
Bear Case
$62.31
-42.5%
Low target
Base Case
$102.33
-5.6%
Avg target
Bull Case
$121.34
+12.0%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$122.21
-11.3% from high
52-Week Low
$28.66
+278.1% from low
50-Day SMA
$53.13
+103.9% vs SMA
200-Day SMA
$69.00
+57.0% vs SMA
RSI (14)
26.0
Oversold
Target vs 52W High
$102.33
-16.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +11.9%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +16.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.8%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +30.5%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +172.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.7%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +173.7%